|
|
|
| home > white papers > Driving ROI: The Case for Investing in Contract & Site Regulatory Document Management Services - DrugDev |
|
|
 WHITE PAPERS |
|
DrugDev
|
|
Driving ROI: The Case for Investing in Contract & Site Regulatory Document Management Services
|
|
With tight timelines and complicated regulatory documentation requirements, getting a clinical trial up and running quickly is easier said than done. Key milestones can be achieved only after the successful negotiation of clinical trial agreements and completion of essential regulatory documents. Many clinical trials are hindered by inefficient, labor-intensive processes. Prolonged, inefficient activation can hamper investigator satisfaction and, ultimately, have a negative bottom-line impact for sponsors and CROs. In addition, the Sunshine Act is heightening the importance of financial disclosure in clinical trials. Without a robust financial disclosure strategy, sponsors cannot ensure that physician self-reported financial disclosure data are aligned with the payment data being reported through the Sunshine Act, increasing financial and regulatory risk.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Merck to Provide ProvantageŽ End-to-End Services to Acticor Biotech SAS
More info >> |
|
 |
White Papers |
 |
|
Crunch Time: The Impact of Serialisation Requirements on Packaging Operations
PCI Pharma Services
The deadlines for including unique product identifiers on prescription drugs is putting a strain on multiple parts of the industry, much of which is ill-prepared to meet the target. Here, we look to the experience of a company that is ahead of the curve for lessons on how to manage and ease the transition to serialisation.
More info >> |
|
 |
Industry Events |
 |
7th American Drug Delivery & Formulation Summit
28-29 August 2017, The Westin Copley Place Boston Hotel
Innovative solutions to the greatest challenges in pharmaceutical development
More info >> |
|
|
|
